Chris Chorley

Associate Director, Global Regulatory CMC, ASO Early Development Lead at Biogen

Speaker

Chris has worked in the pharmaceutical industry for approximately 15 years, beginning his career as a research scientist for AstraZeneca before moving into regulatory affairs in 2011. He held positions of increasing responsibility with Pharmalink Consulting (latterly Genpact Pharmalink) and Ipsen, before joining Biogen in 2020 where he currently leads the regulatory CMC early development activities for oligonucleotide development programs in Phase 1 and 2. Chris holds a master’s degree in chemistry from the University of York, UK.